Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00341744 · ClinicalTrials.gov registry record
Providing Access to the Visual Environment
A clinical trial of Vision Impairment, sponsored by Vanderbilt University.
- Recruiting
- Registry status
- 795
- Enrollment target
- 1
- Study location
NCT00341744: Recruiting study of Vision Impairment, sponsored by Vanderbilt University.
NCT00341744 is a study of Vision Impairment that is actively recruiting participants, run by Vanderbilt University. The registered enrollment target is 795 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00341744, a study of Vision Impairment, is actively recruiting participants, sponsored by Vanderbilt University.
- RECRUITING
- Registry status
- 795 participants
- Enrollment target
- 1
- Study location
Study Summary
Providing Access to the Visual Environment is a pediatric low vision grant which has the ability to provide comprehensive, interdisciplinary low vision rehabilitation services to every child in Tennessee with a vision impairment. Children, ages 3-21, with best-corrected vision of 20/50 or worse in the better seeing eye are prescribed optical devices to improve their visual functioning and trained to use the devices.
Primary Outcome
Training with external optical devices to improve visual outcome
Conditions Studied
Study Locations (1)
Tennessee
- Saige Wilkins - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 795 participants |
| Start Date | 2001-07 |
| Est. Completion | 2028-12 |
What NCT00341744 shows while recruiting
NCT00341744 is an observational study that tracks outcomes without assigning an intervention. The registered 795 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Vision Impairment appearing as the primary indexed condition, and to 0 interventions.
NCT00341744 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00341744 about?
NCT00341744 is a clinical study titled "Providing Access to the Visual Environment". Providing Access to the Visual Environment is a pediatric low vision grant which has the ability to provide comprehensive, interdisciplinary low vision rehabilitation services to every child in Tennessee with a vision impairment. Children, ages 3-21, with best-corrected vision of 20/50 or worse in t...
What is the current status of trial NCT00341744?
This trial is currently recruiting. The enrollment target is 795 participants. The study started on 2001-07. Estimated completion is 2028-12.
What conditions does trial NCT00341744 study?
This clinical trial studies the following conditions: Vision Impairment.
Who is sponsoring clinical trial NCT00341744?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00341744 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vision Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06208150 · 795 participants · Phase 3
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
- NCT06724172 · 795 participants · NA
CHIME: Comparing Health Interventions for Maternal Equity
- NCT05150691 · 796 participants · Phase 1
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
- NCT06051058 · 798 participants · NA
Care Transitions App for Patients With Multiple Chronic Conditions
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia